CSL
Revenue FY growth 3%
NPAT FY down 6%
RMD
Revenue FY down 12%
NPAT FY flat, 21% of revenue
If you regard those results as doing fine, why do you put PME in the same basket..?
PME
Revenue FY growth 37%
NPAT FY growth 44%, 47% of revenue
Ann: PME Full year results, page-17
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$152.58 |
Change
2.190(1.46%) |
Mkt cap ! $15.94B | |||
| Open | High | Low | Value | Volume |
| $150.64 | $152.58 | $149.21 | $24.53M | 161.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 143 | $151.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $152.64 | 780 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| PME (ASX) Chart |